RadNet (RDNT) Non-Current Deferred Tax Liability (2010 - 2026)
RadNet's (RDNT) quarterly Non-Current Deferred Tax Liability came in at $39.0 million in Q2 2026, up 81.92% year-over-year from $21.4 million in Q2 2025, and up 14.22% quarter-over-quarter from $34.2 million in Q1 2026.
Analysis
RadNet (RDNT) Non-Current Deferred Tax Liability (2010 - 2026) Analysis & Trends
RadNet has disclosed Non-Current Deferred Tax Liability across 14 years of filings, most recently posting $39.0 million for Q2 2026.
- In Q2 2026, Non-Current Deferred Tax Liability rose 81.92% year-over-year to $39.0 million; the TTM figure through Jun 2026 stood at $39.0 million (up 81.92% YoY), while the FY2025 annual figure was $21.9 million, down 90.59% from the prior year.
- Non-Current Deferred Tax Liability came in at $39.0 million for Q2 2026 at RadNet, up from $34.2 million in the prior quarter.
- In the past five years, Non-Current Deferred Tax Liability ranged from a high of $232.7 million in Q4 2024 to a low of $10.0 million in Q2 2023.
- Average Non-Current Deferred Tax Liability over 5 years is $64.6 million, with a median of $21.7 million recorded in 2025.
- The largest YoY upside for Non-Current Deferred Tax Liability was 90.31% in 2025 against a maximum downside of 90.59% in 2025.
- Over 5 years, Non-Current Deferred Tax Liability stood at $225.6 million in 2022, then fell by 6.02% to $212.0 million in 2023, then climbed by 9.76% to $232.7 million in 2024, then plunged by 90.59% to $21.9 million in 2025, then surged by 78.08% to $39.0 million in 2026.
- Per Business Quant data, the three most recent Non-Current Deferred Tax Liability figures were $39.0 million in Q2 2026, $34.2 million in Q1 2026, and $21.9 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Davita | 11.76 Bn | 12.63 Bn | 1.16 Bn |
| 2 | RadNet | 5.98 Bn | 5.55 Bn | 88.08 Mn |
| 3 | Concentra Group Holdings Parent | 4.52 Bn | 4.39 Bn | 192.10 Mn |
| 4 | Privia Health | 2.51 Bn | 2.15 Bn | - |
| 5 | Pediatrix Medical | 2.11 Bn | 1.70 Bn | - |
| 6 | Progyny | 2.10 Bn | 1.86 Bn | 89.30 Mn |
| 7 | Fresenius Medical Care AG | 2.07 Bn | 1.37 Bn | 1.52 Bn |
| 8 | Surgery Partners | 1.73 Bn | 2.95 Bn | 622.10 Mn |
| 9 | U S Physical Therapy | 1.23 Bn | 1.52 Bn | 41.94 Mn |
| 10 | Starling Oncology | 699.26 Mn | 658.17 Mn | 27.17 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 39.01 Mn |
| Mar 31, 2026 | 34.15 Mn |
| Dec 31, 2025 | 21.90 Mn |
| Jun 30, 2025 | 21.44 Mn |
| Mar 31, 2025 | 27.56 Mn |
| Dec 31, 2024 | 232.70 Mn |
| Sep 30, 2024 | 20.80 Mn |
| Jun 30, 2024 | 17.47 Mn |
| Mar 31, 2024 | 14.48 Mn |
| Dec 31, 2023 | 212.00 Mn |
| Sep 30, 2023 | 16.65 Mn |
| Jun 30, 2023 | 10.01 Mn |
| Mar 31, 2023 | 10.41 Mn |
| Dec 31, 2022 | 225.57 Mn |
| Dec 31, 2021 | 195.70 Mn |
| Dec 31, 2017 | 36.69 Mn |
| Dec 31, 2016 | 55.33 Mn |
| Dec 31, 2015 | 51.92 Mn |
| Dec 31, 2014 | 48.32 Mn |
| Dec 31, 2013 | 42.37 Mn |